As of 2025-06-16, the Relative Valuation of Translate Bio Inc (TBIO) is (49,047.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.23 USD, the upside of Translate Bio Inc based on Relative Valuation is -1518603.5%.
The range of the Relative Valuation is (40,961.43) - (65,949.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 39.8x | 26.8x |
| Forward P/E multiples | 24.7x - 47.6x | 32.4x |
| Fair Price | (40,961.43) - (65,949.22) | (49,047.66) |
| Upside | -1268255.6% - -2041871.6% | -1518603.5% |
| Date | P/E |
| 2025-05-30 | -0.00 |
| 2025-05-29 | -0.00 |
| 2025-05-28 | -0.00 |
| 2025-05-13 | -0.00 |
| 2025-05-08 | -0.00 |
| 2025-05-07 | -0.00 |
| 2025-05-06 | -0.00 |
| 2025-05-05 | -0.00 |
| 2025-05-02 | -0.00 |
| 2025-05-01 | -0.00 |
| 2025-04-30 | -0.00 |
| 2025-04-29 | -0.00 |
| 2025-04-28 | -0.00 |
| 2025-04-25 | -0.00 |
| 2025-04-24 | -0.00 |
| 2025-04-23 | -0.00 |
| 2025-04-22 | -0.00 |
| 2025-04-21 | -0.00 |
| 2025-04-17 | -0.00 |
| 2025-04-16 | -0.00 |
| 2025-04-15 | -0.00 |
| 2025-04-14 | -0.00 |
| 2025-04-11 | -0.00 |
| 2025-04-10 | -0.00 |
| 2025-04-09 | -0.00 |
| 2025-04-08 | -0.00 |
| 2025-04-07 | -0.00 |
| 2025-04-04 | -0.00 |
| 2025-04-03 | -0.00 |
| 2025-04-02 | -0.00 |
| 2025-03-31 | -0.00 |
| 2025-03-28 | -0.00 |
| 2025-03-27 | -0.00 |
| 2025-03-26 | -0.00 |
| 2025-03-25 | -0.00 |
| 2025-03-24 | -0.00 |
| 2025-03-20 | -0.00 |
| 2025-03-19 | -0.00 |
| 2025-03-18 | -0.00 |
| 2025-03-17 | -0.00 |
| 2025-03-14 | -0.00 |
| 2025-03-13 | -0.00 |
| 2025-03-12 | -0.00 |
| 2025-03-11 | -0.00 |
| 2025-03-10 | -0.00 |